Lansoprazole Delayed-Release Orally Disintegrating Tablets, 30 mg, 100 Tablets (10 x 10 unit-dose) blister pack, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534 NDC 68382-772-77
Published December 23, 2020 · Recall initiated: December 3, 2020
Summary
FDA records drug Class II recall D-0146-2021, published December 23, 2020 and initiated December 3, 2020. Recalling firm: Zydus Pharmaceuticals (USA) Inc; Status: Terminated; Reported quantity: 22,848 cartons; Lot: M900412 December 2020 M904772 February 2021 M915745 October 2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications
What to do
Voluntary: Firm initiated · Letter
Get an email if LANSOPRAZOLE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LANSOPRAZOLE
- Manufacturer
- Zydus Pharmaceuticals (USA) Inc
- Distributor
- Nationwide
- Lot
- M900412 December 2020 M904772 February 2021 M915745 October 2021
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALansoprazole Delayed-Release Orally Disintegrating Tablets, 35 mg, 100-count blisters per carton, 10 Packs ofAugust 3, 2022
- FDALansoprazole Delayed-Release Orally Disintegrating Tablets, 15 mg, 100-count blisters per carton, 10 Packs ofAugust 3, 2022
- FDALansoprazole Delayed-Release Orally Disintegrating Tablets, 30 mg, 10 Packs of 10 Tablets each, 100 TabletsMay 11, 2022
- FDALansoprazole Delayed-Release Capsules, USP, 30 mg, 90-count bottle, Rx Only, Manufactured By: Dr. Reddy'sApril 6, 2022
- FDALansoprazole Delayed-Release Orally Disintegrating Tablets 15 mg, 100 Tablets (10x10 unit dose) blister pack,December 23, 2020
- FDAFentanyl, 250 mcg/ 5mL, Injection for IV or IM use, Rx only, SCA Pharmaceuticals, 8821 Knoedl Ct., LittleDecember 23, 2020
Questions about this recall
Was Lansoprazole Delayed-Release Orally Disintegrating Tablets, 30 mg, 100 Tablets (10 x 10 unit-dose) blister pack, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534 NDC 68382-772-77 recalled?
Yes. FDA published recall D-0146-2021 on December 23, 2020. Reported hazard: Failed Dissolution Specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LANSOPRAZOLE.